Orgenesis Inc. (ORGS) Stock Forecast

OTC Pink: ORGSAnalyst ratings, price target and estimates.

ORGS analyst forecast

as of October 21, 2026
Analyst consensus
Strong buy
5.00 / 5 from 1 analysts
Price target
$6.00
average of analyst targets
Upside to target
+13,536.4%
from the latest close
Next earnings
—
52-week range
$0.00 – $0.91

ORGS analyst ratings

1 analysts
Strong buy
1100%
Buy
00%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

ORGS price target

Price $0.04Target $6.00
52-week low $0.0052-week high $0.91

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

ORGS earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; ORGS beat in 0 of 11.

What analysts expect from ORGS

1 analysts cover Orgenesis; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $6.00, 13,536.4% above the latest close of $0.04. Orgenesis beat the EPS estimate in 0 of the last 11 quarters.

Related: ORGS income statement, ORGS key metrics, ORGS chart. See the ORGS stock overview for the latest quote and news.

ORGS forecast FAQ

What is Orgenesis's price target?

The average analyst price target for Orgenesis is $6.00, 13,536.4% above the latest close of $0.04.

Is Orgenesis a buy, hold or sell?

Of 1 analysts covering Orgenesis, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

Does Orgenesis usually beat earnings estimates?

Orgenesis reported EPS at or above the analyst estimate in 0 of the last 11 quarters.

Biotechnology: forecast